Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by quinlashon Dec 01, 2023 5:16pm
158 Views
Post# 35764465

RE:RE:RE:Eventual Legalization of Cannabis in the US

RE:RE:RE:Eventual Legalization of Cannabis in the USCannabis producers in Canada are facing one common challenge in terms of profitability with that being Taxes.  Canadian reform is overdue (now by months) where the Canadian Federal Government is expected to come forth with new regulations.  Canadian Producers have been pushing for lower tax rates which will translate directly to their profits, if / when that should materialize.

US Legalization could be said to be tied up in political games, this may be the easiest way to summarize it as we have an election coming up and either, or both, parties may be trying to delay progress on this front for their own political gain during the election.  Regardless we now have 24 US States with Legal Rec and 44 with either Rec or Medical Legalized.  Eventually the scales will tip to the majority of US states with legal rec and the Fed will have little to no choice but the Legalize on the Federal Level.

Canopy Growth sold BioSteel in order to cut a financial drain on the business and improve their reports.  During interviews it was noted that the company was seeing as much as 50% to 60% of their expenses being due to BioSteel.  By selling this off one can (beyond reason) expect notable improvements in the upcoming financial reports.  Partial funds from the sale of BioSteel are also expected to go towards exists debt, again another improvement for future reports.

Consolidation of shares on Canopy Growth is a well-beaten-to-death topic on this forum and, as noted numerous times, the Company has a long as Sept of 2024 (according to deepdive) to see the SP over $1 USD to avoid the move.  Considering the basic Price to Book Value of the Compnay exceeds this level is it not unreasonable to speculate that the time available will be more than ample to see these targets achieved.

Not to down-play the consolidation concern, we cannot say for sure if the CEO of Canopy Growth will not opt to consolidate prior to Sept of 2024 however there is no pressing need at this time so (again I speculate) that this will not be occurring anywhere in the near to mid-term.

Best Regards,

Q










<< Previous
Bullboard Posts
Next >>